John Coustas - 18 Mar 2026 Form 3 Insider Report for Danaos Corp (DAC)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: DAC
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 10:10:45 UTC
Source filing: View source filing
Reporting owner signature: /s/ Evangelos Politis, Attorney-in-Fact

Key filing fact

John Coustas filed Form 3 for Danaos Corp (DAC) on 18 Mar 2026.

Key facts

This page summarizes John Coustas's Form 3 filing for Danaos Corp (DAC).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Mar 2026, 10:10.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001389183 Primary reporting owner

Coustas John

Relationship: Chief Executive Officer, Director
Address: 14 AKTI KONDYLI, 185 45 PIRAEUS, GREECE
Signature: /s/ Evangelos Politis, Attorney-in-Fact
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DAC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 9,538,502
Date: 18 Mar 2026
Ownership: By Danaos Investment Limited as Trustee of the 883 Trust
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares held indirectly through Danaos Investment Limited ("DIL") as Trustee of the 883 Trust. The beneficiaries of the 883 Trust are Dr. Coustas and members of his family. The board of directors of DIL consists of five members, none of whom are beneficiaries of the 883 Trust or members of the Coustas family, and has voting and dispositive control over the shares held by the 883 Trust. Dr. Coustas has certain powers to remove and replace DIL as trustee of the 883 Trust. Dr. Coustas disclaims beneficial ownership of such shares purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that Dr. Coustas is a beneficial owner of the shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.

SEC remarks

Exhibit 24 - Power of Attorney